Respiratory Motion, Inc. is a privately held medical device company based in Waltham, Massachusetts focused on the development and commercialization of innovative devices to monitor respiration. Its mission is to create respiratory technologies and products that help clinicians and hospitals improve patient safety and outcomes.
Location: United States, Massachusetts, Watertown
Employees: 11-50
Phone: +1 781-373-1636
Total raised: $6M
Founded date: 2010
Investors 7
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.03.2014 | Series B | $6M | - |
Mentions in press and media 6
| Date | Title | Description |
| 21.09.2024 | Motion: Creative Analytics And Research Company Secures $30 Million (Series B) | Motion, a creative analytics and research platform used by creative strategists, announced that it had secured $30 million in Series B funding led by Inovia. Threshold Ventures participated, as did existing investors Headline, Abstract Vent... |
| 09.09.2020 | Motion Analysis App Company Mustard Raises $1.7 Million | Mustard — the world’s first elite-level motion analysis app for broad athletics coaching — announced recently that it raised $1.7 million in funding Mustard — the world’s first elite-level motion analysis app for broad athletics coaching — ... |
| 06.03.2014 | Respiratory Motion raises $6M, touts results from ventilation monitoring study | Respiratory Motion is on a roll, landing nearly $6 million in new funding and unveiling positive results from a clinical study of its ExSpiron non-invasive respiratory monitor. The Waltham, Mass.-based hopes to close the Series B round with... |
| 26.02.2014 | Respiratory Motion, Inc. Raises $5.8M in First Closing of Series B Financing | Easton Capital Leads Round to Support Market Entry of Innovative System Poised to Help Sharply Reduce the Incidence of Post-Operative Respiratory Depression; Accomplished Healthcare Vet John Geisel Appointed. WALTHAM, Mass.–(BUSINESS WIRE)–... |
| 26.02.2014 | Respiratory Motion Raises $5.8M in Series B Funding | Respiratory Motion, a Waltham, Mass.-based medical device company, raised $5.8m in Series B financing. The round was led by Easton Capital, with participation from early investors. In conjunction with the funding, John Friedman, Managing Di... |
| 27.03.2013 | Medical device maker with respiratory systems for COPD, respiratory distress syndrome raises $26.4M | Investors in the company include GE Asset Management, Cross Creek Capital and Integral Capital Partners, QuestMark Partners and Kaiser Permanente Ventures. Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public... |